(P303) Clinical and Economic Impact of a Collaborative Pharmacist-Endocrinology Practice Structure

Approximately 11.3% (37.3 million) of Americans were diagnosed with diabetes in 2019, with an additional 1.4 million new diagnoses occurring every year. Subsequently, $327 billion dollars in costs related to diabetes were spent in 2017. Furthermore, the growing prevalence of diabetes is met with an ongoing shortage of primary care and endocrinology providers. As a result, healthcare practices need to implement innovative practice structures to properly address the prevalence of diabetes in the US. This poster explores this topic by reviewing the clinical and economic impact on people with diabetes after implementing a collaborative clinical pharmacist and outpatient endocrinology practice structure.